MedPath

厦门恩成制药有限公司

Ownership
-
Established
2006-12-22
Employees
-
Market Cap
-
Website
www.xmeczy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Betahistine mesilate Tablets

Product Name
甲磺酸倍他司汀片
Approval Number
国药准字H20253804
Approval Date
Apr 1, 2025
NMPA

Lansoprazole and Sodium Bicarbonate Capsules

Product Name
兰索拉唑碳酸氢钠胶囊
Approval Number
国药准字H20240019
Approval Date
May 28, 2024
NMPA

Omeprazole and Sodium Bicarbonate Capsules(Ⅱ)

Product Name
奥美拉唑碳酸氢钠胶囊(Ⅱ)
Approval Number
国药准字H20243667
Approval Date
May 8, 2024
NMPA

Esomeprazole Magnesium and Sodium Bicarbonate Capsules

Product Name
艾司奥美拉唑镁碳酸氢钠胶囊
Approval Number
国药准字H20240015
Approval Date
May 8, 2024
NMPA

Oral Rehydration Salts Powder(Ⅲ)

Product Name
口服补液盐散(Ⅲ)
Approval Number
国药准字H20173410
Approval Date
Nov 30, 2022
NMPA

Omeprazole and Sodium Bicarbonate Capsules

Product Name
奥美拉唑碳酸氢钠胶囊
Approval Number
国药准字H20150023
Approval Date
Jan 22, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.